news2.gif (1504 bytes)

Gov. Paul Patton recognizes UK, U of L lung cancer researchers

Contact:
 Maureen McArthur

or

Terry Sebastian (502) 564-2611

~

Twenty researchers from the University of Kentucky and the University of Louisville received awards from Gov. Paul Patton today for lung cancer research. The $3.8 million comes from the Tobacco Settlement money.

~

LEXINGTON, KY (Oct. 17, 2001) -- Twenty researchers from the University of Kentucky and the University of Louisville received awards from Gov. Paul Patton today for lung cancer research. The $3.8 million comes from the Tobacco Settlement money.

The grants are part of the Lung Cancer Research Project that Gov. Patton and lawmakers created in the 2000 General Assembly to combined efforts of UK and U of L to become national leaders in lung cancer basic research, early detection, diagnosis and treatment.

The Lung Cancer Research Project is a 20-year initiative that was designed to receive 20 percent of all moneys in the Tobacco Master Settlement Agreement for this collaborative partnership between the two universities.

The project's nine-member board helped select the 20 grant recipients from a total of 54 initial requests.

Donald Miller, M.D., director of the James Graham Brown Cancer Center at the University of Louisville, and Alfred Cohen, M.D., director of the Markey Cancer Center at the University of Kentucky, will help oversee the direction of the 20 grants, which were funded for two years.

UK researchers who received grants and their studies include:

Mansoor Ahmed -  TGF-beta signaling and radiation response in lung carcinoma

Douglas A. Andres - Novel ras-related GTPase in lung cancer

Stephen A. Brown - Radioprotective agents in NSCLC therapy

Ramesh C. Gupta - Etiology and prevention of lung cancer: Biomarker development in clinical studies

Louis B. Hersh - A gene therapeutic approach for the treatment of lung cancer

Edward Hirschowitz - Therapeutic investigation of dendritic cell vaccines in NSCLC

Marcos A. Oliveira - A novel chemo-radio sensitizing target: PARP-2 activation domain

William St. Clair - Novel anticancer agents to promote the efficacy of contemporary or GRID radiation therapy for treatment of lung cancer

H. Peter Spielman - Pre-clinical studies of novel ras function inhibitors to treat lung cancer

John R. Yannelli - Use of dendritic cells to present non-small cell lung cancer associated antigens

 


Comments to Betsy Hall, Last Modified: October 14, 2003
Copyright 1999, University of Kentucky Chandler Medical Center
Terms, Conditions & Privacy Statement